
New Genetic Marker Associated with Enhanced Immunotherapy Survival in Ovarian and Other Cancers
Ovarian clear cell carcinoma (OCCC) has long posed a formidable challenge in oncology due to its aggressive nature and limited treatment options. This rare subtype of ovarian cancer exhibits resistance to conventional therapies, leaving patients with few …